Sitemap

History

Here is what SKYVE has achieved to make the world a better place to live in.

2025

2024

2023

2022

2021

2020

2019

2017

2015

2014

2013

2012

2011

2010

2025

Jul

  • Obtained MFDS approval for 'EVERFIX' (Bone Cemet Containing Gentamicin Sulfate)

May

  • Received Best Podium Award from the The Korean Hip Society

    Obtained MFDS approval for 'ZIFT' (AI-based 3D segmentation software for knee joint)

Mar

  • Obtained MFDS approval for 'Onknee-U' (knee surgery simulation software)

Feb

  • Acquired ISO 13485 certification
2024

Dec

  • Awarded the 18th Korea Outstanding Patent Grand Prize

Oct

  • Received Best Paper Award from the Korean Orthopaedic Association

Jan

  • Relocated office building
2023

Dec

  • Awarded the 17th Korea Outstanding Patent Grand Prize

Nov

  • Obtained U.S. FDA approval for PNK KNEE (artificial knee joint)

    Acquired Inno-Biz certification for Technology Innovation

Aug

  • Obtained venture business certification

Jul

  • Changed the company’s name to SKYVE

    Reached 15,000 customers storing stem cells in cell banking
2022

Dec

  • Awarded the 16th Korea Outstanding Patent Grand Prize

Apr

  • Developed and distributed patient-specific surgical techniques

    Obtained approval from the Ministry of Food and Drug Safety for the PNK artificial joint

Jan

  • Launched the RXTEM cosmetics brand and entered global markets
2021

Dec

  • Awarded the 15th Korea Outstanding Patent Grand Prize

Jun

  • Acquired GMP certification for a medical device manufacturing facility

    Formed a partnership with Johnson & Johnson’s Artificial Joint Business Division

    Established the Health & Beauty Business Division and launched health functional food for Joints
2020

Jan

  • Rated T4 in Technology Credit Evaluation (recognized for its technological competitiveness, innovation, and business potential)
2019

Jan

  • ISO 9001 certified for quality management systems, and selected as a small but strong company by the Ministry of Employment and Labor
2017

Jan

  • Awarded the 11th Korea Outstanding Patent Grand Prize
2015

Jan

  • Established Good Manufacturing Practice (GMP) manufacturing business
2014

Jan

  • Acquired certification for a medical device laboratory and a manufacturing license for medical devices

    Launched PSI (patient-specific instrumentation for artificial joints)
2013

Jan

  • Established a medical device laboratory to develop artificial joints
    Established a cell banking division (for stem cell storage programs)
2012

Apr

  • Converted to TJC Life corporation
2011

Jan

  • Formed a partnership with Smith & Nephew’s Artificial Joint Division
2010

Jan

  • Established TJC

Privacy Policy

● Consent to Collection and Use of Personal Information


We collect and use your personal information as outlined below in order to respond to your inquiry. The collected data will be used solely for the purpose of handling your request and will be safely destroyed once the purpose of use has been fulfilled, in accordance with applicable laws.


Collected Information: Name, region, affiliation, email address, contact number, etc.

Purpose of Collection: To receive and respond to customer inquiries, and to manage inquiry history

Retention Period: Until the purpose of use is achieved (or retained for the period required by relevant laws, if applicable)


This consent is required to process your inquiry, and you have the right to refuse.

However, please note that if you do not consent, you may not be able to use the inquiry service.

Close

Refusing to collect email addresses unauthorizedly

닫기

문의사항

스카이브에 관심 가져주셔서 감사합니다.
문의를 남겨 주시면 빠른 시일 내에 연락 드리겠습니다.

문의하기

관심 비즈니스 *

스카이브에 대해 어떻게 알게 되셨습니까?

자동등록방지
닫기